CSF1R and neoplasm: Further approaches feature T cells and NK-92 cells (an immortalized natural killer cell line that can be employed for therapy) engineered with a CAR against colony-stimulating factor 1 receptor (CSF1R), a receptor expressed on both TAMs in the tumor microenvironment and M2 macrophages.